Nature Reviews Drug Discovery 2018-03-28

George Yancopoulos

Index: 10.1038/nrd.2018.41

Full Text: HTML

Abstract

George Yancopoulos George Yancopoulos, Published online: 28 March 2018; doi:10.1038/nrd.2018.41George Yancopoulos, CSO of Regeneron, discusses his 30 years at Regeneron, the company's evolving growth plans and the recent launch of a precompetitive collaboration to sequence 500,000 UK Biobank exomes.